Similar articles

• Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group.

  Malmström PU, Rintala E, Wahlqvist R, Hellström P, Hellsten S, Hannisdal E. Malmström PU, et al. J Urol. 1996 Jun;155(6):1903-6. J Urol. 1996. PMID: 8618283 Clinical Trial.
• Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.

  Koch MO, Coussens D. Koch MO, et al. Semin Urol. 1993 Feb;11(1):14-9. Semin Urol. 1993. PMID: 8465122 Review. No abstract available.
• Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy.

  Soloway MS, Lopez AE, Patel J, Lu Y. Soloway MS, et al. Cancer. 1994 Apr 1;73(7):1926-31. doi: 10.1002/1097-0142(19940401)73:7<1926::aid-cncr2820730725>3.0.co;2-q. Cancer. 1994. PMID: 8137219
• Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder.

  Sternberg CN, Pansadoro V, Calabro F, Marini L, van Rijn A, Carli PD, Giannarelli D, Platania A, Rossetti A. Sternberg CN, et al. Ann Oncol. 1999 Nov;10(11):1301-5. doi: 10.1023/a:1008350518083. Ann Oncol. 1999. PMID: 10631456 Clinical Trial.
• Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors.

  Honma I, Masumori N, Sato E, Takayanagi A, Takahashi A, Itoh N, Tamagawa M, Sato MA, Tsukamoto T. Honma I, et al. Urology. 2004 Oct;64(4):744-8. doi: 10.1016/j.urology.2004.05.003. Urology. 2004. PMID: 15491713 Review.